CompletedEarly Phase 1

AvenovaTM as a Sterile Skin Preparation Agent

United States21 participantsStarted 2018-12-01

Plain-language summary

Aim 1: To determine in vivo capability of AvenovaTM against common cutaneous microbial biome on human skin Aim 2: To compare to povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol against AvenovaTM as a sterile skin agent

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults age 18 and above able to provide informed consent to participate Adults attending Dr. Wendy Lee Oculoplastics Clinic Exclusion Criteria: * Adults unable to consent * Individuals who less than 18 years of age * Prisoners * Pregnant women - while these cleansing agents are used on pregnant women as standard cleansing agents, effects to fetus unknown * Patients currently using oral or topical antimicrobial agents * History of skin infection to facial injectable of surgery * Inability to tolerate cleansing procedure * Inability to sit comfortably for 15 - 30 minutes

What they're measuring

Compare the efficacy of Avenova to other standard of care cleansing agents: growth vs. no growth

Timeframe: 12 months

Trial details

NCT IDNCT02990013

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-20

View on ClinicalTrials.gov More Cleaning Product Causing Toxic Effect trials